Other neonatal morbidity · women with eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · women with pre‐eclampsia
1 finding from 1 review
Other neonatal morbidity: neonatal respiratory morbidity · women with pre‐eclampsia
It is very uncertain whether prevention of eclampsia: maintenance regimen by continuous infusion changes other neonatal morbidity: neonatal respiratory morbidity compared with a serial IV bolus regimen (very low certainty).
1 finding from 1 review
Recurrence of convulsions · women with eclampsia
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes recurrence of convulsions: lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).
1 finding from 1 review
Severe morbidity (renal failure): lower dose versus Pritchard regimen · women with eclampsia
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes severe morbidity (renal failure): lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).
1 finding from 1 review
Side effects · women with eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cramp frequency (percentage change from baseline at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (percentage change from baseline at 4 weeks) (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (mean number of cramps per week on treatment at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review
Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · pregnant women with leg cramps
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cramp duration (≥ 1 minute at 4 weeks) · pregnant women with leg cramps
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Cramp frequency (responder analysis: 25% or better reduction at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (responder analysis: 25% or better reduction at 4… (high certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (mean number of cramps per week on treatment at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp frequency (mean number of cramps per week on treatment at 4… (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp intensity (moderate or worse at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp intensity (moderate or worse at 4 weeks) (moderate certainty).
1 finding from 1 review
Intervention not reported
Cramp duration (≥ 1 minute at 4 weeks) · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in cramp duration (≥ 1 minute at 4 weeks) (low certainty).
1 finding from 1 review
Intervention not reported
Major adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
It is very uncertain whether the intervention changes major adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events · for effects on cramps, people (other than pregnant women) with muscle cramps (largely older adults); for adverse events, all populations
The intervention showed no clear difference in minor adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Cramp frequency (percentage change from baseline at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review
Intervention not reported
Cramp frequency (responder analysis: 25% or better reduction at 4 weeks) · pregnant women with leg cramps
1 finding from 1 review
FEV1 · adults and children with acute exacerbation of asthma
1 finding from 1 review
PEF (L/min) · adults and children with acute exacerbation of asthma
2 findings from 1 review